HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Substance P induces adverse myocardial remodelling via a mechanism involving cardiac mast cells.

AbstractAIMS:
Substance P and neurokinin A (NKA) are sensory nerve neuropeptides encoded by the TAC1 gene. Substance P is a mast cell secretagogue and mast cells are known to play a role in adverse myocardial remodelling. Therefore, we wondered whether substance P and/or NKA modulates myocardial remodelling via a mast cell-mediated mechanism.
METHODS AND RESULTS:
Volume overload was induced by aortocaval fistula in TAC1(-/-) mice and their respective wild types. Left ventricular internal diameter of wild-type (WT) fistulas increased by 31.9%; this was prevented in TAC1(-/-) mice (4.2%). Matrix metalloproteinase (MMP) activity was significantly increased in WT fistula mice and was prevented in TAC1(-/-) mice. Myocardial collagen volume fraction was decreased in WT fistula mice; this collagen degradation was not observed in the TAC1(-/-) group. There were no significant differences between any groups in tumour necrosis factor (TNF)-α or cell death. Cardiac mast cells were isolated from rat hearts and stimulated with substance P or NKA. We found that these cells degranulated only to substance P, via the neurokinin-1 receptor. To determine the effect of substance P on mast cells in vivo, volume overload was created in Sprague-Dawley rats treated with the NK-1 receptor antagonist L732138 (5 mg/kg/day) for a period of 3 days. L732138 prevented: (i) increases in cardiac mast cell density; (ii) increased myocardial TNF-α; and (iii) collagen degradation.
CONCLUSIONS:
Our studies suggest that substance P may be important in mediating adverse myocardial remodelling secondary to volume overload by activating cardiac mast cells, leading to increased TNF-α and MMP activation with subsequent degradation of the extracellular matrix.
AuthorsGiselle C Meléndez, Jianping Li, Brittany A Law, Joseph S Janicki, Scott C Supowit, Scott P Levick
JournalCardiovascular research (Cardiovasc Res) Vol. 92 Issue 3 Pg. 420-9 (Dec 01 2011) ISSN: 1755-3245 [Electronic] England
PMID21908647 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Neurokinin-1 Receptor Antagonists
  • Receptors, Neurokinin-1
  • Tumor Necrosis Factor-alpha
  • 3,5-bis(trifluoromethyl)benzyl N-acetyltryptophan
  • Substance P
  • Neurokinin A
  • Tryptophan
  • Collagen
  • Matrix Metalloproteinases
Topics
  • Animals
  • Apoptosis
  • Cell Degranulation
  • Collagen (metabolism)
  • Disease Models, Animal
  • Heart Failure (diagnostic imaging, genetics, metabolism, pathology)
  • In Situ Nick-End Labeling
  • Male
  • Mast Cells (metabolism, pathology)
  • Matrix Metalloproteinases (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Myocardium (metabolism, pathology)
  • Neurokinin A (genetics, metabolism)
  • Neurokinin-1 Receptor Antagonists
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Neurokinin-1 (metabolism)
  • Substance P (deficiency, genetics, metabolism)
  • Time Factors
  • Tryptophan (analogs & derivatives, pharmacology)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Ultrasonography
  • Ventricular Remodeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: